<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:mp ids='MP_0002038'>Carcinoma</z:mp> of the large bowel is the fourth commonest <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> worldwide </plain></SENT>
<SENT sid="1" pm="."><plain>The most frequent site for <z:e sem="disease" ids="C0027627" disease_type="Neoplastic Process" abbrv="mets">metastasis</z:e> is the liver </plain></SENT>
<SENT sid="2" pm="."><plain>Overall 30% of patients develop <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> during the course of their illness; of these, 23% to 47% are synchronous lesions </plain></SENT>
<SENT sid="3" pm="."><plain>These data are based on western studies </plain></SENT>
<SENT sid="4" pm="."><plain>No data are published on patients with <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> from Egypt </plain></SENT>
<SENT sid="5" pm="."><plain>We aimed to assess the incidence of colorectal <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> in Egyptian patients and to evaluate the differences in the clinicopathological features and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> behavior in patients with and without <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> </plain></SENT>
<SENT sid="6" pm="."><plain>One hundred forty eight patients were prospectively enrolled in the study </plain></SENT>
<SENT sid="7" pm="."><plain>Patients were classified into metastatic group (n=78) and non metastatic group (n=70) </plain></SENT>
<SENT sid="8" pm="."><plain>In the two groups macroscopic features compared including: <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> size (2 cm, 2-5 cm, and &gt;5 cm), site of <z:e sem="disease" ids="C0677930" disease_type="Neoplastic Process" abbrv="">primary tumor</z:e>, side of liver involved, clinical symptoms and liver profile </plain></SENT>
<SENT sid="9" pm="."><plain>Carcino-embryonic antigen (CEA) and <z:e sem="disease" ids="C1306459,C0006826" disease_type="Neoplastic Process" abbrv="">cancer</z:e> antigen (CA19.9) levels were recorded </plain></SENT>
<SENT sid="10" pm="."><plain>At microscopy, <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> differentiation, invasion and nodal status were evaluated </plain></SENT>
<SENT sid="11" pm="."><plain>No difference was found in the distribution of the primary site and size of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> </plain></SENT>
<SENT sid="12" pm="."><plain><z:hpo ids='HP_0000952'>Jaundice</z:hpo>, <z:hpo ids='HP_0002240'>hepatomegaly</z:hpo> and <z:hpo ids='HP_0001541'>ascites</z:hpo> were significantly higher in patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastases</z:e> </plain></SENT>
<SENT sid="13" pm="."><plain>Patients with <z:e sem="disease" ids="C0494165" disease_type="Neoplastic Process" abbrv="">liver metastasis</z:e> had higher levels of CEA, CA19.9, higher frequency of vascular invasion and nodal involvement </plain></SENT>
</text></document>